or
forgot password

    • cancer clinical trials in birmingham, AL

    • Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Cardiac Toxicity, Lymphoma
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Leukemia
    Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lymphoma
    ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Pancreatic Cancer
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Leukemia
    Chemotherapy in Treating Patients With Sarcoma of the Uterus
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Endometrial Cancer, Sarcoma
    Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Purpura, Thrombocytopenic, Idiopathic
    Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Colorectal Cancer
    Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Prostate Cancer
    Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Cervical Cancer
    Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Leukemia, Lymphoma
    Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer
    Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Endometrial Cancer
    Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Colorectal Cancer
    The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
    Univ of Alabama at Birmingham - Pediatric
    Birmingham, Alabama 35233
    HIV Infections, HIV Wasting Syndrome, Lipodystrophy
    EMD 121974 in Treating Patients With Progressive or Recurrent Glioma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Systemic Lupus Erythematosus
    Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Systemic Lupus Erythematosus
    Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth
    University of Alabama Comprehensive Cancer Center

    Trial Locations
    University of Alabama Comprehensive Cancer Center
    Children's Hospital of Alabama
    Herpes Simplex
    Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer
    Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Leukemia
    Immunotoxin Therapy in Treating Patients With Malignant Glioma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Prostate Cancer
    Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Colorectal Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women
    Univ of Alabama at Birmingham
    Birmingham, Alabama 35294
    HIV Infections, Papilloma
    Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Cervical Cancer
    Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Sarcoma
    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Graft Versus Host Disease, Lymphoma
    Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Lymphoma
    Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Leukemia
    Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Esophageal Cancer, Gastric Cancer
    Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Karenitecin in Treating Patients With Recurrent Malignant Glioma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
    University of Alabama Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Pancreatic Cancer, Perioperative/Postoperative Complications
    Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Infection
    Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Endometrial Cancer
    Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Kidney Cancer
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Brain and Central Nervous System Tumors
    Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    Veterans Affairs Medical Center - Birmingham
    Birmingham, Alabama 35233
    Lymphoma
    Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Leukemia
    R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
    University of Alabama at Birmingham (M1149)
    Birmingham, Alabama 35233
    Neurofibroma, Plexiform, Neurofibromatosis Type I
    Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Colorectal Cancer
    Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Sarcoma
    Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Sarcoma
    Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Endometrial Cancer
    Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
    Comprehensive Cancer Center at University of Alabama at Birmingham

    Trial Locations
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Brookwood Medical Center
    Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer
    Radiofrequency Ablation in Treating Patients With Bone Metastases
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Breast Cancer, Hot Flashes, Menopausal Symptoms
    Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Brain Tumor, Central Nervous System Tumor